FILORGA was founded in 1978 by Michel Tordjman, a French doctor of aesthetic medicine, with a fascination for cellular biology. Michel Tordjman pioneered NCTF® , New Cellular Treatment Factor, a unique injectable solution that prevents, slows and corrects the effects of skin ageing.

Dr Tordjman’s innovations were originally intended to provide dermatologists and doctors of aesthetic medicine with an extensive range of treatment solutions: peeling treatments, hyaluronic acid injections and mesotherapy.

NCTF® now constitutes an undisputed skin rejuvenation benchmark. It is regularly cited in medical articles and other professional publications around the world. This unique compound comprises more than 50 active ingredients. It recreates an ideal cellular ecosystem and boosts the factors required for beautiful skin:

+147% Increase in fibroblast stimulation*
+ 256% Increase in collagen stimulation*
+ 90% Reduction in free radicals*

With over 3 million bottles, NCTF® is now the leading polyrevitalising agent used in mesotherapy treatment throughout the world; the compound is cited in numerous medical reviews and is discussed widely at medical congresses.



Laboratoires FILORGA was founded by Michel Tordjman, a French doctor of aesthetic medicine and enthusiastic cellular biologist. Before Botox took off, he developed hyaluronic acid-based injectable products for the medical profession and created NCTC, an anti-ageing mesotherapy product that subsequently became the brand's best-selling NCTF® product.


NCTC was rebranded NCTF®, an anti-ageing mesotherapy product that revitalises and hydrates tired or dull skin and removes lines. The effectiveness of this unique is proved.


Laboratoires FILORGA launched MEDI-COSMETIQUE®, a range of over-the-counter cosmetic products for general consumers, inspired directly by non-surgical anti-ageing procedures.


Laboratoires FILORGA launched X-HA3, the first polyvalent reticulated injectable hyaluronic acid product that can be used simultaneously on different parts of the face. In 2010, the injectable range was extended to include X-HA Volume (to combat deep lines and restore volume) and MHA18 (superficial lines).


FILORGA inaugurated its SPA in Paris.


In January, Laboratoires FILORGA acquired new technology in non-surgical anti-ageing procedures and well being like photo-bio-modulation. This technique uses LEDs to improve the apparence of the skin and reduce stretch marks or hair loss.

February saw the launch of the SKIN PERFUSION line, developed for medical spas and high-end salons.


FILORGA created and inaugurated FILORGA MANUFACTURING, a custom-built production unit where ART FILLER®, the brand’s new range of hyaluronic acid-based filler injections, can be prepared in optimum health and safety conditions. Only seven facilities of this kind exist around the world.